The future of protein therapeutics is within proximity
InduPro brings emergent technologies and exceptional teams together to close in on new, innovative drug designs that induce proximity. It’s a groundbreaking advance in how the world thinks about and treats disease.
Our two-fold strategy and the platforms that support it
Proximity by design is bringing together two molecules intentionally, in precisely the right way, to modify their signaling. This allows us to alter their biology in ways never before seen.
We address proximity in two ways:
We study and map inherent proximity.
We manipulate molecular interactions through induced proximity.
Without the right technology, inducing proximity is random at best – so we built our own platforms to remove the guesswork:
Microenvironment Surface Mapping
Our comprehensive Membrane Interactomics database (MInt), identifies novel targets across a wide spectrum of diseases. An interactive data repository of inherently proximal surface proteins, it defines therapeutic opportunities for modulating signaling pathways.
Induced Proximity of Surface Proteins
Our protein neighborhood mapping toolbox lets us manipulate protein pairings. This allows us to create novel signaling pathways, new ways to address challenging biology, and new logic gates.
A library of targeted designs and dual targeting reagents helps us enhance protein targeting specificity.
We take an end-to-end approach
The more complicated the research, the more it demands a clearly articulated approach to support it. Our approach is built on these end-to-end pillars:
an industry leading toolbox of binders to modifier enzymes
the most compelling applications of induced proximity
new biology and targets through our platforms
robust clinical molecules that address unmet medical need
Our investors in shaping the future
These diverse investors believe in our mission – and in our ability to see it through.